Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial

Abstract Background The treatment of acute promyelocytic leukemia (APL) has been revolutionized in the past two decades by the advent of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). It suggests that non-high-risk APL patients can be cured without chemotherapy. However, ATRA plus chemot...

Повний опис

Бібліографічні деталі

Автори:	Xinxin Zhang, Huiyun Zhang, Limei Chen, Mengchang Wang, Jieying Xi, Xin Liu, Ming Xie, Dengzhe Li, Ekamjyot Singh Gulati, Sha Gong, Huaiyu Wang
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMC 2018-09-01
Серія:	Trials
Предмети:	Acute promyelocytic leukemia Arsenic trioxide All-trans retinoic acid Hydroxyurea Mannitol
Онлайн доступ:	http://link.springer.com/article/10.1186/s13063-018-2812-3
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!